Source: BBC
Salinomycin, an antibiotic, has demonstrated itself to kill breast cancer stem cells more effectively than current chemotherapy drugs.
Dr. John Stingl, a British Cancer researcher at Cambridge, has offered the opinion that, “This is one of the biggest advances we have seen this year in this area of research.” This area being cancer stem cells. This area also being “very early” in the research process and so far limited only to trials in test tubes and in mice.
Research that is promising is always worth reporting, even if it is several years away from a clinical application.
posted by David Marc Schwadron, Esq.